Chemical Structure : ICEC 0942 hydrochloride
CAS No.: 1805789-54-1
货号: PC-35095Not For Human Use, Lab Use Only.
ICEC 0942 (Samuraciclib, CT7001) hydrochloride is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1980 | In stock | |
10 mg | ¥3280 | In stock | |
25 mg | ¥5480 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ICEC 0942 (Samuraciclib, CT7001) hydrochloride is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM).
ICEC0942 displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2, CDK5 and CDK9.
ICEC0942 demonstrates sensitivity against a wide range of cancer types with GI50 values ranging between 0.2-0.3 uM.
ICEC0942 shows substantial anti-tumor effects in xenografts of both breast and colorectal cancers, also exhibits complete growth arrest of ER-positive tumor xenografts combined with tamoxifen.
分子量 | 430.981 | |
分子式 | C22H31ClN6O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol hydrochloride |
1. Hazel P, et al. ChemMedChem. 2017 Mar 7;12(5):372-380.
2. Patel H, et al. Mol Cancer Ther. 2018 Mar 15. pii: molcanther.0847.2016.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright